BioPharma Dive May 6, 2024
With many chemotherapy and ADHD drugs stuck in stubborn shortages, several agencies are looking for new solutions to boost supply.
Drug shortages hit a new high in the first quarter of 2024, forcing patients and doctors to scramble to secure ADHD medications, cancer treatments and other needed drugs. While shortages have been rising for some time, the persisting struggle to get them under control has spurred new calls for action.
The American Hospital Association in February issued a plea to Congress to make legislative changes. Around the same time, the Federal Trade Commission requested public comment as part of an inquiry into how group purchasing organizations and drug wholesalers might be contributing to shortages. Patients on the hunt for ADHD...
Today's Sponsors
Today's Sponsor